| CR (n = 9) | non-CR (n = 6) | p-value |
---|---|---|---|
Duration of MTX (month) | 50 (7–172) | 81 (40–234) | 0.19 |
Dose of MTX (mg/week) | 8.0 (4.0–16.0) | 9.0 (6.0–16.0) | 0.14 |
Number of sites | 5 (1–99) | 3 (1–41) | 0.30 |
SUVmax | 9.2 (2.8–47.1) | 13.9 (0–24.9) | 0.21 |
WBMTV (ml) | 26.6 (0–362.6) | 22.7 (0–250.1) | 0.36 |
WBTLG (ml) | 111.6 (0–2180.9) | 152.1 (0–1052.1) | 0.25 |
sIL-2R (U/ml) | 758 (310–3157) | 795 (259–5861) | 0.16 |